Drug Database
Back to search

United States· US:17156-021_bc294a45-4008-4476-b7a4-9475b18d43a2

Indium in 111 Oxyquinoline

A medicinal product containing indium in-111 oxyquinoline, registered in United States by Medi-Physics Inc. dba GE Healthcare..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedIndium in 111 OxyquinolineATC—REGISTER NO.US:17156-021_bc294a45…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about indium in-111 oxyquinolineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
INDIUM IN-111 OXYQUINOLINE
Manufacturer
Medi-Physics Inc. dba GE Healthcare.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    1715602101
    1 VIAL in 1 BOX (17156-021-01) / 1 mL in 1 VIAL
  • ndc11
    17156-021-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Indium in-111 oxyquinoline in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All indium in-111 oxyquinoline products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Belgium · Indium (111in) Oxinate Curium, Indium-(111in) Oxinate Curium
  • Germany · Indium (In111) Oxinate Curium Netherlands
  • Denmark · Indium (In-111) Oxinate
  • Spain · Indio (111in) Oxina Curium Pharma Spain
  • France · Oxinate D’indium (111in) Curiumpharma
  • Italy · Indio (111in) Ossina
  • Netherlands · Indium (In111) Oxinate Drn 4908 Curium Netherlands B.V.
  • Sweden · Indium (In111) Oxinat Curiumpharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/948aa74b-1437-4fb4-ab3b-3f3a56649bb7
GET /v1/drugs/948aa74b-1437-4fb4-ab3b-3f3a56649bb7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "1",
  "substance": "INDIUM IN-111 OXYQUINOLINE",
  "productndc": "17156-021",
  "dosage_form": "SOLUTION",
  "dea_schedule": null,
  "strength_unit": "ug/mL",
  "application_number": "NDA019044",
  "marketing_category": "NDA"
}
API referenceMCP serverPlans

See everything about indium in-111 oxyquinoline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console